Nav: Home

Current Placebo News and Events | Page 2

Current Placebo News and Events, Placebo News Articles.
Sort By: Most Relevant | Most Viewed
Page 2 of 25 | 1000 Results
Well-known drug has less risk for preterm delivery in PCOS
Metformin significantly reduces the risk of late miscarriages and preterm births for women with PCOS. (2019-04-01)
Common medication used in pregnancy may lead to obesity in children
Metformin, a common drug used for type 2 diabetes, has several benefits when the mother has PCOS. (2019-03-27)
Second potential male birth control pill passes human safety tests
A new male birth control pill passed tests of safety and tolerability when healthy men used it daily for a month, and it produced hormone responses consistent with effective contraception, according to researchers at two institutions testing the drug. (2019-03-25)
Automated drug delivery system combats low blood sugar after weight-loss surgery
A new automated drug delivery system can help prevent dangerously low blood sugar in patients who have undergone weight-loss surgery, according to a study to be presented Monday, March 25, at ENDO 2019, the Endocrine Society's annual meeting in New Orleans, La. (2019-03-25)
Improved PCOS symptoms correlate with gut bacterial composition
Symptoms of polycystic ovary syndrome (PCOS) improved with exposure to healthy bacteria in the gut, according to a study in a mouse model of this common women's endocrine disorder. (2019-03-23)
Apixaban plus P2Y12 inhibitor and no aspirin safest for patients with both AFib and ACS
Patients at high risk for heart attacks, strokes and blood clots who were treated with a novel blood thinner (apixaban) and an antiplatelet drug such as clopidogrel had a significantly lower risk of bleeding and being hospitalized compared with patients who received an older blood-thinning medication such as warfarin, according to research presented at the American College of Cardiology's 68th Annual Scientific Session. (2019-03-18)
Statin add-on may offer new/another option for reducing LDL-C in high-risk patients
Patients at high risk for a heart attack or stroke who took an investigational drug in addition to a statin had significantly lower LDL, or 'bad' cholesterol, after 12 weeks compared to similar patients who took a placebo in addition to statin therapy, according to research presented at the American College of Cardiology's 68th Annual Scientific Session. (2019-03-18)
Fast-acting agent shows promise in reversing effects of ticagrelor
PB2452 provides immediate and sustained reversal of ticagrelor's antiplatelet effects (2019-03-17)
Vaccine study confirms sensitivity of cholera test
Recently, the sensitivity of fecal microbiological cultures for detecting cholera has come under question. (2019-03-14)
New cholesterol-lowering drug could help patients unable to take statins
A new class of oral cholesterol-lowering drug could help patients unable to take statins due to side effects. (2019-03-13)
Cutting the standard dose of medication for acute mountain sickness in half does not reduce its effectiveness
A new study published in Wilderness & Environmental Medicine demonstrated that trekkers and climbers taking a lower dose of acetazolamide (62.5 mg twice daily) were no more likely to develop acute mountain sickness (AMS) symptoms than those who took twice that amount, which is the standard prophylactic dose. (2019-03-11)
New treatment offers potentially promising results for the possibility of slowing, stopping, or even reversing Parkinson's disease
A pioneering clinical trials program that delivered an experimental treatment directly to the brain offers hope that it may be possible to restore the cells damaged in Parkinson's disease. (2019-02-27)
Lowering blood pressure and cholesterol may not improve thinking and memory
While drugs that lower blood pressure and cholesterol have been shown to be beneficial for heart health, a new study has found that two such drugs may not provide a similar benefit to the brain. (2019-02-27)
Immunotherapy for egg allergy may allow patients to eat egg safely long after treatment
After completing up to four years of egg oral immunotherapy (eOIT) treatment, certain participants were able to safely incorporate egg into their diet for five years. (2019-02-23)
Clinical trial: Prenatal DHA prevents blood-pressure increase from obesity during childhood
A clinical trial at the University of Kansas and KU Medical Center finds pregnant mothers who daily consumed 600 milligrams of DHA -- an omega-3 fatty acid -- protected their offspring from the blood pressure-elevating effects of excessive weight in early childhood. (2019-02-22)
Study finds acetaminophen significantly reduced in-hospital delirium
Patients treated with acetaminophen demonstrated a significant reduction in in-hospital delirium. (2019-02-19)
UTMB develops drug to rejuvenate muscle cells
Researchers from The University of Texas Medical Branch at Galveston have developed a promising drug that has proven to significantly increase muscle size, strength and metabolic state in aged mice, according to a study just published in Biochemical Pharmacology. (2019-02-15)
Even psychological placebos have an effect
Placebo effects do not only occur in medical treatment -- placebos can also work when psychological effects are attributed to them. (2019-02-05)
Research pushes back on benefits of compounded topical pain creams
In an effort to reduce chronic pain, many people look for hope by paying $20 to thousands of dollars for a tube of prescription topical pain cream or gel. (2019-02-05)
Researchers report positive findings with dasotraline for ADHD in children ages 6-12
A new study in children aged 6 to 12 years of dasotraline, a promising new treatment for attention deficit hyperactivity disorder (ADHD), showed significant improvement in efficacy in the treatment of ADHD compared to placebo beginning at week 1 and continuing throughout the study. (2019-02-04)
New global task force report questions effectiveness of spinal fusion procedures, provides recommendations
There is little to no evidence that two surgical procedures used to fuse crumbled vertebrae following a spinal fracture caused by osteoporosis reduce pain for patients any better than non-surgical or placebo procedures, according to a new report from a global task force of bone health experts published today in the Journal of Bone and Mineral Research (JBMR). (2019-01-24)
First clinical study shows mavoglurant improves eye gaze behavior in fragile X syndrome patients
Researchers at Rush University Medical Center and the MIND Institute at UC Davis have found that mavoglurant, an experimental drug known as an mGluR5 negative modulator, can positively modify a key characteristic behavior in individuals with fragile X syndrome (FXS). (2019-01-17)
Poo transplant effective treatment for chronic bowel condition
Poo transplant or 'Faecal microbiota transplantation' (FMT) can successfully treat patients with ulcerative colitis, new research from the University of Adelaide shows. (2019-01-15)
B-group vitamins can improve concentration among people with first episode psychosis
The study, led by Dr Colin O'Donnell, now at Letterkenny University Hospital, and Dr Kelly Allott from Orygen, explored the impact of increasing a person's intake of vitamins B12, B6, and folic acid [vitamin B9] after studies in people with schizophrenia revealed that increased intake of these vitamins could decrease patients' levels of an amino acid called homocysteine and improve their symptoms. (2019-01-14)
Millions on prescription sleeping pills would sleep through a fire alarm
Widely prescribed 'benzodiazepine' sleeping pills suppress the sleeping brain's ability to wake us when it senses a threat. (2019-01-11)
Genetics may influence the effects of vitamin E on cancer risk
A new study led by researchers from Brigham and Women's Hospital investigated whether taking vitamin E supplements could affect risk of cancer and found that genetic variations in the gene COMT influenced whether vitamin E decreased or increased risk of developing cancer during and after the study periods. (2019-01-08)
Botulinum toxin reduces chronic migraine attacks, compared to placebo
A growing body of evidence supports the effectiveness of botulinum toxin injections in reducing the frequency of chronic migraine headaches, concludes an updated review and analysis in the January issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS). (2019-01-03)
How exercise reduces belly fat in humans
Some of you may have made a New Year's resolution to hit the gym to tackle that annoying belly fat. (2018-12-27)
Opioids vs. placebo, nonopioid alternatives for chronic noncancer pain
An estimated 50 million adults in the United States were living with chronic noncancer pain in 2016 and many of them were prescribed opioid medications, even though a clinical benefit is uncertain. (2018-12-18)
Research finds opioids may help chronic pain, a little
In a study published today by the Journal of the American Medical Association (JAMA), McMaster University researchers reviewed 96 clinical trials with more than 26,000 participants and found opioids provide only small improvements in pain, physical functioning and sleep quality compared to a placebo. (2018-12-18)
Monitoring lung function at home in teens with Duchenne muscular dystrophy
Heart and lung complications are responsible for much of the morbidity and mortality associated with Duchenne muscular dystrophy (DMD). (2018-12-17)
Probiotics could help millions of patients suffering from bipolar disorder
About 3 million people in the US are diagnosed every year with bipolar disorder, a psychiatric condition characterized by dramatic shifts in mood from depression to mania. (2018-12-13)
The Lancet Neurology: Cannabis-based drug in combination with other anti-spasticity
Oral spray containing two compounds derived from the cannabis plant reduced spasticity compared with placebo in patients already taking anti-spasticity drugs. (2018-12-13)
Oxybutynin decreased frequency of hot flashes, improved QOL for breast cancer survivors
Treatment with oxybutynin helped reduce the frequency and intensity of hot flashes for women who could not take hormone replacement, including breast cancer survivors, according to results of a trial presented at the 2018 San Antonio Breast Cancer Symposium. (2018-12-07)
Mayo-led study: Drug reduces hot flashes, improves breast cancer survivor quality of life
Research led by oncologists Roberto Leon-Ferre, M.D. and Charles Loprinzi, M.D. of Mayo Clinic has found that the drug oxybutynin helps to reduce the frequency and intensity of hot flashes in women who are unable to take hormone replacement therapy, including breast cancer survivors. (2018-12-07)
Low-dose tamoxifen reduced recurrence and new disease for patients with DCIS, LCIS, and ADH
Treatment with a low dose of tamoxifen (5 mg per day) halved the risk of disease recurrence and new disease for women who had been treated with surgery following a diagnosis of breast intraepithelial neoplasia compared with placebo, and it did not cause more serious adverse events, according to data from the randomized, phase III TAM-01 clinical trial presented at the 2018 San Antonio Breast Cancer Symposium. (2018-12-06)
Liquid biopsies in SOLAR-1 trial predict benefit of Alpelisib in PIK3CA-mutant breast cancer
Liquid biopsy-based assessment of PIK3CA mutational status served as a better indicator of progression-free survival compared with analysis of tissue biopsy in breast cancer patients enrolled in the phase III clinical trial SOLAR-1, according to data presented at the 2018 San Antonio Breast Cancer Symposium. (2018-12-06)
Pot withdrawal eased for dependent users
A new drug can help people diagnosed with cannabis use disorder reduce withdrawal symptoms and marijuana use, a new Yale-led study published Dec. (2018-12-06)
Cannabis-based compound may reduce seizures in children with epilepsy
Interest has been growing in the use of cannabinoids--the active chemicals in cannabis or marijuana-- for the treatment of epilepsy in children. (2018-12-05)
Common antidepressant does not aid stroke recovery, study finds
Stroke patients prescribed a common antidepressant show no improvement compared with those given a dummy drug, a study led by the University of Edinburgh has found. (2018-12-05)
Page 2 of 25 | 1000 Results
   First   Previous   Next      Last   

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#530 Why Aren't We Dead Yet?
We only notice our immune systems when they aren't working properly, or when they're under attack. How does our immune system understand what bits of us are us, and what bits are invading germs and viruses? How different are human immune systems from the immune systems of other creatures? And is the immune system so often the target of sketchy medical advice? Those questions and more, this week in our conversation with author Idan Ben-Barak about his book "Why Aren't We Dead Yet?: The Survivor’s Guide to the Immune System".